Luminex Corp (LMNX)
The COmpany develops, manufactures and sells proprietary biological testing technologies with applications throughout the life sciences industry.
Recs
When the overly optimistic FOMC says that household spending will be "constrained" by sluggish income growth, ongoing job losses, lower household wealth, and tight credit AND Shanghai stocks hit a seven-week low, then you know this bear market rally is finally over!
Recs
A small company with a market cap bellow 1 billion who sits at the center of an industry with its flow cytometry patents and technology. The list of their partners is truely impressive. This is a platform technology company who licences its tech to so many companies that it's difficult to keep track. Luminex is extremely well positioned to ride the wave of diagnostic upgrades that our medical system will eventually need to do. Many of the clinical tests we do are time consuming, labour intensive and slow. The current uncertainty in the health care market makes short term predictions about this and so many other diagnostic companies difficult but the significant funds unlocked as part of the stimulus package will certainly be a big accelerator for the research market that Luminex serves. The market seems to have partailly priced in the effect of the stimulus package for companies like Illumina, Life, Affymetrix and Luminex but might have overlooked the long term advantage that first movers can have in science diagnostics. Companies that are well positioned to sell their machines now might be 'locking in' for a significant amount of time. Their research platforms could become standards for a relatively long time. Research plateforms could also become stepping stones to the clinical market.
Recs
The 1929-1930 equity rally (coming out of The Great Depression) lasted 147 days and the market was up 46%. It has been the same amount of time since the March, 2009 low and we are up about the same percentage. It’s déjà vu (paramnesia), so prepare for a drop of about the same percentage (85%).
Recs
This stock looks like it has support around $18.50 plus the daily stochastics are at the very bottom. The risk to reward seems great on this one. Wish me luck.
Recs
I need this revenue grower to fill the "Long" void in my portfolio. Technically set for a short-term gain.
Recs
help doctors identifying the virus helps the patient - add value and minimize waste !
Recs
Recs
great company
Recs
I am bullish on this stock. I think that they have solid management, good foundation, and are ever increasing their testing. I see good things coming from LMNX in the future.
Recs
A rally in the stock. Dump this dog.
Recs
Interesting chart, but no thank you...
Recs
Its diversified holdings of precious metals and fossil fuel should help it perform well despite the down tick after the US elections many other stock will experience.
Recs
long term uptrend with a nice pullback here - nice candle with a close above the 50dma - somewhat oversold right here

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 13 of 13